Trending Now
CTAD 2020 Picks Cassava Sciences Inc.’s (NASDAQ:SAVA) Phase 2b Sumifilam Study...
Cassava Sciences Inc. (NASDAQ:SAVA) has announced that its phase 2b clinical study results for sumifilam have been picked for late-breaking oral presentation by the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Lineage Cell Therapeutics Inc (NYSEAMERICAN:LCTX) Reveals Interim Findings From Phase 1/2a...
Lineage Cell Therapeutics Inc (NYSEAMERICAN:LCTX) recently provided an interim update of the results from the Phase 1/2a clinical trial of OpRegen as a potential...
MAKE IT MODERN
LATEST REVIEWS
The FDA Grants Breakthrough Therapy Designation To Insmed Incorporated’s (NASDAQ:INSM) Brensicatib...
Insmed Incorporated (NASDAQ:INSM) announced the FDA has granted its brensocatib (INS1007) a breakthrough therapy designation for the reduction of exacerbations in the treatment non-cystic...
MAKE IT MODERN
PERFORMANCE TRAINING
AIM ImmunoTech (NYSEAMERICAN:AIM) Receives IRB Approval For Enrolment Of COVID-19-Induced Fatigue Patients In Ampligen...
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) has announced the receipt of an Institutional Review Board Approval for expansion of the AMP-511 Expanded Access Program clinical study...
Vaxart Inc. (NASDAQ:VXRT) Picks Its Lead Oral Coronavirus Vaccine Candidate And Contracts KindredBio As...
Vaxart Inc. (NASDAQ:VXRT) has announced that it has chosen its lead coronavirus vaccine candidate as well as contracted KindredBio to produce the vaccine in...
The Next Wave for Virus Testing Stocks (HOLX, ALST, FLGT)
While vaccines are rolling out rapidly around the developed world, and uptake is expected to produce some version of herd immunity within...
ABVC BioPharma Inc. (NASDAQ: ABVC) Receives Approval From Taiwan Central Institution Review Board For...
ABVC BioPharma Inc. (NASDAQ: ABVC) has announced that the Taiwan Central Institution Review Board (CIRB) has approved the start of Phase II Part 2...
The Virus Testing Stocks Pullback Opportunity (CODX, FLGT, ALST, LH)
The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus...
MAKE IT MODERN
